Fluorescite    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
215ファロー四徴症1

215. ファロー四徴症 [臨床試験数:19,薬物数:35(DrugBank:16),標的遺伝子数:16,標的パスウェイ数:47
Searched query = "Tetralogy of Fallot", "Fallot tetralogy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 19 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04017975
(ClinicalTrials.gov)
December 20, 201910/7/2019Optical Tissue Identification for Myocardial ArchitectureOptical Tissue Identification for Myocardial Architecture (OPTIMA Study)Ventricular Septal Defect;Complete Atrioventricular Canal;Tetralogy of Fallot With Pulmonary StenosisDrug: Fluorescite;Device: Cellvizio 100 Series System with Confocal MiniprobesAditya KazaNational Heart, Lung, and Blood Institute (NHLBI)RecruitingN/A18 YearsAll70Phase 2United States